Earnings & Investor News · Week of Oct 26, 2026
Regional banks report Q3 gains: the week in earnings and investor news
Regional banks led a week of third-quarter reports, alongside a REIT, a biotech update, a seafood takeover deal and a listing event.
Third-quarter results from community and regional banks dominated the week. HBT Financial reported net income of $31.4 million, or $0.86 diluted earnings per share, and Ponce Financial Group reported net income available to common stockholders of $18.0 million, up from $8.2 million in the prior quarter. MainStreet Bancshares and HBT Financial both reported net interest margins up two basis points from the previous quarter, while MainStreet also took a $1.9 million provision for credit losses tied to commercial real estate. First Resource Bancorp described its quarter as a record.
Outside banking, Easterly Government Properties reported Core FFO of $0.78 per share and a set of lease and debt changes. Acumen Pharmaceuticals said it expects topline Phase 2 results for sabirnetug in November 2026. In deals, High Liner Foods agreed to be acquired by Umios for C$27.00 per share in cash. FF EAI Robotics Ecosystem scheduled a Listing Ceremony and Investor Day for October 26.
HBT Financial, Inc.
HBT FINANCIAL, INC. ANNOUNCES
HBT Financial reported third-quarter 2026 net income of $31.4 million, or $0.86 diluted earnings per share, compared with $27.8 million in the second quarter and $19.8 million a year earlier. The company says its tax-equivalent net interest margin rose 2 basis points to 4.40% as maturing fixed-rate loans repriced higher, and that adjusted ROAA was 1.85%.
Ponce Financial Group, Inc.
Ponce Financial Group, Inc. Reports Third Quarter 2026 Results
Ponce Financial Group reported third-quarter net income available to common stockholders of $18.0 million, or $0.76 per diluted share, up from $8.2 million in the second quarter and $6.2 million a year earlier. The company says the result included a $5.9 million benefit for income taxes, against $57.5 million in total interest and dividend income and $23.5 million in interest expense.
Easterly Government Properties, Inc.
EASTERLY GOVERNMENT PROPERTIES
Easterly Government Properties reported third-quarter net income of $5.7 million, or $0.12 per fully diluted share, and Core FFO of $38.0 million, or $0.78 per share. The REIT says it used $6.4 million of cash to extinguish the mortgage on USFS II - Albuquerque, renewed USCIS - Lincoln on a new 15-year lease and received full repayment of a $35.6 million Bedford construction loan.
MainStreet Bancshares, Inc.
MainStreet Bancshares, Inc.
MainStreet Bancshares reported third-quarter net income of $3.6 million, or $0.43 per common share, with net interest income rising to $18.8 million for a fourth consecutive quarterly increase. The company says a $1.9 million provision for credit losses, which it attributes to targeted credit remediation amid commercial real estate adjustments, reduced earnings per common share by $0.21.
High Liner Foods Incorporated
High Liner Foods Enters into Agreement to Be Acquired by Umios for C$27.00 per Share in Cash
High Liner Foods has agreed to be acquired by Umios for C$27.00 per share in cash in a deal the company describes as fully financed. High Liner Foods says the combination would pair Umios' global sourcing with its processing operations and brands to form a North American platform.
FF EAI Robotics Ecosystem Inc.
FFR to Hold Listing Ceremony and Investor Day on October 26; FFAI Announces Rescheduling of YT Jia's Investor Weekly Report to October 26
FF EAI Robotics Ecosystem Inc. (NASDAQ: FFR) said it would hold its Listing Ceremony and Investor Day on October 26, with management outlining the company's plans. Faraday Future also moved its Investor Weekly Report from founder and Global CEO YT Jia to the same date.
First Resource Bank
First Resource Bancorp, Inc. Reports Record Third Quarter 2026 Financial Results
First Resource Bancorp reported what it calls record financial results for the third quarter ended September 30, 2026. President and CEO Lauren C. Ranalli said the bank has been growing its balance sheet and profitability at the same time.
Acumen Pharmaceuticals, Inc.
Acumen Pharmaceuticals Reports Third Quarter 2026 Financial Results
Acumen Pharmaceuticals reported third-quarter 2026 results and said it expects to report topline results from its ALTITUDE-AD Phase 2 study of sabirnetug in early Alzheimer's disease in November 2026. The company also says it is continuing IND-enabling work on its Enhanced Brain Delivery program, which pairs blood-brain barrier-penetrating technology with an AβO-selective antibody.
This roundup is written with AI assistance from the press releases listed above, using only what they state. The releases are the companies' own announcements, not Business News Talks reporting.